The FTSE 100’s biggest company is crushing the coronavirus. I’d buy its shares today!

This UK household name is powering ahead during the Covid-19 crisis. I’d buy this FTSE 100 share for stability, dividends, and growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

As I wrote towards the end of May, the old FTSE 100 is dead. Four months on from the steepest crash in its history and the UK’s main market index keeps evolving.

The FTSE 100’s new king

Until recently, the surging share price of UK pharma giant AstraZeneca (LSE: AZN) had made it the FTSE 100’s new king. The shares are up a quarter (25.4%) over the past 12 months, driven by enthusiasm about an exciting drugs pipeline. The firm is also a leading candidate to develop a Covid-19 vaccine, briefly driving its share price above £100.

The FTSE 100’s new new king

AstraZeneca’s shares have dropped back about 15% from their all-time high and currently trade at around £86.56. This values the UK’s leading drugmaker at a tidy £113.1bn.

However, thanks to a recent share surge elsewhere, the FTSE 100 has yet another new king. Currently, the FTSE 100’s biggest business by market value is Anglo-Dutch household name Unilever (LSE: ULVR).

As I write, Unilever’s share price hovers around £47.14, valuing this global leader at £122bn – or £8.9bn more than AstraZeneca.

Unilever is built on enormous scale

Here’s a single number to blow you away. Around 2.5bn people – or one in three of the world population – use Unilever products. To me, that’s simply mind-blowing.

Unilever has had a long time to grow. Its origins date back to 1871, when it was built on making butter and margarine. It then moved into manufacturing soap, detergents, and a whole host of other household products.

Today, Unilever has over 400 household brands in its cupboard – far too many to list. In the UK, our favourites include Domestos (cleanser), Dove (soap), Hellmann’s (mayo), Knorr (soup), Lipton (tea), Lynx (deodorant), Magnum (ice cream), and Surf (laundry detergent) – and this list goes on and on.

A FTSE 100 colossus

While other businesses have crashed due to the coronavirus, Unilever’s market leadership in cleansing and hygiene products has proved vital. Last week, the FTSE 100’s #1 unveiled better-than-expected quarterly sales, down only 0.3% in the deepest recession in British history. This caused a one-day surge of nearly 8% in its share price.

At £47.14, Unilever shares are down just 3.8% over the past 12 months, while the wider FTSE 100 has crashed by a fifth. Unilever’s 52-week high of £53.33 was set on 4 September 2019, so it’s slipped 11.6% since. Then again, Unilever shares were an absolute bargain on 16 March, when they slumped to just £35.83. That was a golden opportunity to buy into a world-class business at a low price.

Unilever combines stability, income, and growth

Today, Unilever shares are not so cheap as in March, trading on a price-to-earnings ratio of 22.9 and a dividend yield of 3.1%. Then again, the king of the FTSE 100 keeps churning out quarterly cash dividends, unlike dozens of big firms that have cut, suspended, or cancelled payouts.

Buy Unilever shares before 6 August and you’ll be entitled to the next quarterly dividend of 36.98p, paid on 9 September. Then sit back and watch future dividends come rolling in forever. That’s why I’d buy and hold this FTSE 100 star’s shares today.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Cliffdarcy has no position in any of the shares mentioned. The Motley Fool UK has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »